Cellshoot Therapeutics

BiotechnologySeedTokyo, Japancellshoot.co.jp

Latest round

Seed

Last raised

Aug 2022

Total raised

$1.7M

Investors

3

About Cellshoot Therapeutics

, Cellshoot Therapeutics, Inc. operates as a pharmaceutical research company, providing drug discovery target molecules and creating drug candidates by utilising the technology of intracellular protein pathway analysis. In August 2022, Cellshoot Therapeutics, Inc. Cellshoot Therapeutics provides protein localization and the modification-based covariation network analysis method (PLOM-CON) for extracting and analysing the quantity and quality of proteins from fluorescent antibody-producing cells. The company provides a semi-intact cell sealing method in which molecules are introduced from outside the cells and then into the cells. As of 2023, the company serves industries such as pharmaceuticals, medicine development, and research and development.

Who invested in Cellshoot Therapeutics

3 investors across 1 round

See all investors in Cellshoot Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Aug 1, 2022

    Amount

    $1.7M

    Investors

    Locked

Questions about Cellshoot Therapeutics

Who invested in Cellshoot Therapeutics?

Cellshoot Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Cellshoot Therapeutics raised?

Cellshoot Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Cellshoot Therapeutics last raise money?

Cellshoot Therapeutics's most recent round on record is a Seed, in Aug 2022.

What does Cellshoot Therapeutics do?

Cellshoot Therapeutics is a biotechnology company.

Where is Cellshoot Therapeutics headquartered?

Cellshoot Therapeutics is headquartered in Tokyo, Japan.

Which VCs invest in companies like Cellshoot Therapeutics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Cellshoot Therapeutics's stage. Their profiles are linked below.

Raising like Cellshoot Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.